Advisory Research’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-7,415
Closed -$960K – 340
2020
Q3
$960K Buy
7,415
+4,601
+164% +$605K 0.09% 182
2020
Q2
$316K Buy
+2,814
New +$289K 0.03% 279
2019
Q3
– Sell
-6,922
Closed -$803K – 348
2019
Q2
$803K Sell
6,922
-10,079
-59% -$1.08M 0.02% 270
2019
Q1
$1.79M Sell
17,001
-3,406
-17% -$382K 0.03% 195
2018
Q4
$2.3M Sell
20,407
-20,459
-50% -$2.52M 0.05% 175
2018
Q3
$6.61M Sell
40,866
-297
-0.7% -$42K 0.11% 125
2018
Q2
$4.9M Buy
41,163
+7,755
+23% +$950K 0.08% 149
2018
Q1
$3.93M Sell
33,408
-2,161
-6% -$244K 0.07% 161
2017
Q4
$3.66M Buy
35,569
+2,841
+9% +$255K 0.06% 169
2017
Q3
$2.63M Buy
32,728
+20,414
+166% +$1.48M 0.04% 189
2017
Q2
$828K Buy
+12,314
New +$744K 0.01% 331

Other funds holding PRLB

Advisory Research's PRLB Position: Q4 2020 in Review

Advisory Research sold out of Protolabs (PRLB) in Q4 2020, closing a stake of 7,415 shares — an estimated $960K sold.

Advisory Research first reported a position in PRLB in Q2 2017 and held it in 11 quarters. The position peaked at $6.61M in Q3 2018. 305 funds tracked by Wall St. Rank hold PRLB as of Q4 2020.

  • Advisory Research reported no remaining Protolabs position as of Q4 2020 after selling out during the quarter.
  • Advisory Research sold 7,415 Protolabs shares in Q4 2020, an estimated $960K.
  • Advisory Research first reported a position in Protolabs in Q2 2017 and held it in 11 quarters.
  • Advisory Research's Protolabs position peaked at $6.61M in Q3 2018.
  • 305 funds tracked by Wall St. Rank held Protolabs as of Q4 2020.

Based on Advisory Research's 13F filing for Q4 2020, filed 12 Feb 2021.